Imeik Technology Development Co.,Ltd. (SZSE:300896) Just Recorded An Earnings Miss And Analysts Are Updating Their Numbers

Simply Wall StOct 25 21:36 ET

Imeik Technology DevelopmentLtd (SZSE:300896) Has A Rock Solid Balance Sheet

Simply Wall StOct 24 21:34 ET

imeik technology development (300896.SZ) third-quarter performance stable growth, quality improvement, long-term growth potential promising

Looking at the medical beauty industry from the perspective of the third quarter report, it may be described as a combination of "under pressure with some improvements." Looking back, since 2024, affected by factors such as weak consumer demand, the overall medical beauty market has faced certain growth pressure, combined with the third quarter being the traditional off-season for medical beauty consumption and the existence of a high base effect, the growth rate has generally slowed down. Looking ahead, recent frequent economic stimulus policies and the expected recovery of consumer demand, as well as the stronger momentum in service consumption, provide an opportunity for the medical beauty industry to warm up; the improvement of medical beauty penetration rate, high-quality demand, and so on, will drive the industry towards a stage of high-quality development. The traditional peak season in the fourth quarter has also arrived, and the medical beauty industry may see an increase in growth rate.

Gelonghui FinanceOct 24 05:54 ET

Amex: third quarter report 2024

SZSIOct 23 12:00 ET · Announcements

Q3 revenue growth rate dropped to 1%. Can the next approved botox product in China be featured on imeik technology development? | Interpretations

①In the first three quarters, imeik technology development's performance has shown some growth, but the revenue and net income attributable to shareholders have slowed down. ②In order to seek new growth points, imeik technology development's research and development expenses continue to rise, focusing on the layout of weight management drugs, botulinum toxin and other fields.

cls.cnOct 23 11:43 ET

imeik technology development Q3 revenue increased by 1.10% year-on-year, net income increased by 2.13% | Financial Report Watch

In the first three quarters, the company achieved revenue of approximately 2.376 billion yuan, a year-on-year increase of 9.46%; net income was approximately 1.586 billion yuan, a year-on-year increase of 11.79%. The operational scale of the company is steadily increasing, and the profitability meets market expectations.

wallstreetcnOct 23 09:43 ET